Item 2.02. Results of Operations and Financial Condition.
On November 2, 2009, Vanda Pharmaceuticals Inc. issued a press release relating to its results of operations and financial condition for the third quarter ended September 30, 2009. The full text of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in Item 2.02 of this Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits Exhibit No. Description 99.1 Press release of Vanda Pharmaceuticals Inc. dated November 2, 2009.

---